SRL
NVO

Scientech Research LLC’s Novo Nordisk NVO Stock Holding History

Scientech Research LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,274
Closed -$341K – 453
2026
Q1 		$341K Buy
+9,274
New +$439K 0.28% 101
2025
Q4 		– Sell
-19,624
Closed -$1.09M – 714
2025
Q3 		$1.09M Buy
+19,624
New +$1.15M 0.38% 37
2025
Q1 		– Sell
-4,283
Closed -$368K – 738
2024
Q4 		$368K Buy
+4,283
New +$463K 0.1% 376
2024
Q3 		– Sell
-3,269
Closed -$467K – 774
2024
Q2 		$467K Buy
+3,269
New +$433K 0.1% 349

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Scientech Research LLC's NVO Position: Q2 2026 in Review

Scientech Research LLC sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 9,274 shares — an estimated $341K sold.

Scientech Research LLC first reported a position in NVO in Q2 2024 and held it in 4 quarters. The position peaked at $1.09M in Q3 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Scientech Research LLC reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 9,274 Novo Nordisk shares in Q2 2026, an estimated $341K.
  • Scientech Research LLC first reported a position in Novo Nordisk in Q2 2024 and held it in 4 quarters.
  • Scientech Research LLC's Novo Nordisk position peaked at $1.09M in Q3 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.